Two Sigma Advisers’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-836,100
| Closed | -$37.5M | – | 2428 |
|
|
2024
Q4 | $37.5M | Sell |
836,100
-1,264,600
| -60% | -$70.9M | 0.09% | 202 |
|
|
2024
Q3 | $132M | Buy |
2,100,700
+987,100
| +89% | +$57.6M | 0.31% | 75 |
|
|
2024
Q2 | $65.8M | Buy |
+1,113,600
| New | +$69.7M | 0.15% | 139 |
|
|
2024
Q1 | – | Sell |
-3,205,000
| Closed | -$253M | – | 2484 |
|
|
2023
Q4 | $253M | Sell |
3,205,000
-1,734,500
| -35% | -$123M | 0.59% | 32 |
|
|
2023
Q3 | $345M | Sell |
4,939,500
-832,000
| -14% | -$59M | 0.88% | 20 |
|
|
2023
Q2 | $399M | Buy |
5,771,500
+306,800
| +6% | +$21.8M | 1.02% | 11 |
|
|
2023
Q1 | $406M | Buy |
5,464,700
+4,778,500
| +696% | +$401M | 1.05% | 11 |
|
|
2022
Q4 | $63.9M | Buy |
686,200
+51,600
| +8% | +$4.98M | 0.18% | 121 |
|
|
2022
Q3 | $60.5M | Sell |
634,600
-473,700
| -43% | -$46.9M | 0.18% | 140 |
|
|
2022
Q2 | $103M | Buy |
1,108,300
+1,090,000
| +5,956% | +$106M | 0.29% | 82 |
|
|
2022
Q1 | $1.85M | Sell |
18,300
-32,400
| -64% | -$3.4M | ﹤0.01% | 1305 |
|
|
2021
Q4 | $5.23M | Sell |
50,700
-157,600
| -76% | -$14.6M | 0.01% | 747 |
|
|
2021
Q3 | $17.7M | Buy |
208,300
+198,100
| +1,942% | +$16.6M | 0.05% | 342 |
|
|
2021
Q2 | $851K | Buy |
10,200
+4,900
| +92% | +$401K | ﹤0.01% | 1705 |
|
|
2021
Q1 | $399K | Buy |
+5,300
| New | +$386K | ﹤0.01% | 2101 |
|
|
2020
Q3 | – | Sell |
-4,200
| Closed | -$273K | – | 2440 |
|
|
2020
Q2 | $273K | Sell |
4,200
-186,800
| -98% | -$11.8M | ﹤0.01% | 2158 |
|
|
2020
Q1 | $11.3M | Buy |
+191,000
| New | +$12.8M | 0.04% | 440 |
|
|
2018
Q2 | – | Sell |
-1,878,219
| Closed | -$117M | – | 2386 |
|
|
2018
Q1 | $117M | Sell |
1,878,219
-431,887
| -19% | -$31M | 0.32% | 74 |
|
|
2017
Q4 | $167M | Buy |
2,310,106
+1,541,487
| +201% | +$112M | 0.45% | 41 |
|
|
2017
Q3 | $62.5M | Sell |
768,619
-1,320,950
| -63% | -$104M | 0.18% | 147 |
|
|
2017
Q2 | $168M | Buy |
2,089,569
+911,050
| +77% | +$71.9M | 0.55% | 31 |
|
|
2017
Q1 | $92.5M | Sell |
1,178,519
-1,643,155
| -58% | -$131M | 0.3% | 79 |
|
|
2016
Q4 | $223M | Buy |
2,821,674
+1,400,987
| +99% | +$113M | 0.85% | 7 |
|
|
2016
Q3 | $126M | Buy |
1,420,687
+1,062,872
| +297% | +$100M | 0.54% | 38 |
|
|
2016
Q2 | $34.3M | Buy |
+357,815
| New | +$35.7M | 0.17% | 141 |
|
|
2015
Q4 | – | Sell |
-69,080
| Closed | -$6.67M | – | 1899 |
|
|
2015
Q3 | $6.67M | Buy |
+69,080
| New | +$7.26M | 0.04% | 400 |
|
|
2015
Q1 | – | Sell |
-2,786
| Closed | -$268K | – | 1995 |
|
|
2014
Q4 | $268K | Sell |
2,786
-7,300
| -72% | -$643K | ﹤0.01% | 2021 |
|
|
2014
Q3 | $803K | Buy |
10,086
+5,000
| +98% | +$394K | 0.01% | 1264 |
|
|
2014
Q2 | $383K | Buy |
+5,086
| New | +$384K | ﹤0.01% | 1849 |
|
|
2014
Q1 | – | Sell |
-9,986
| Closed | -$705K | – | 2312 |
|
|
2013
Q4 | $715K | Sell |
9,986
-7,200
| -42% | -$463K | 0.01% | 1352 |
|
|
2013
Q3 | $975K | Sell |
17,186
-7,800
| -31% | -$465K | 0.01% | 970 |
|
|
2013
Q2 | $1.43M | Buy |
+24,986
| New | +$1.45M | 0.02% | 669 |
|
Other funds holding CVS
Two Sigma Advisers's CVS Position: Q1 2025 in Review
Two Sigma Advisers sold out of CVS Health (CVS) in Q1 2025, closing a stake of 836,100 shares — an estimated $37.5M sold.
Two Sigma Advisers first reported a position in CVS in Q2 2013 and held it in 32 quarters. The position peaked at $406M in Q1 2023. 1,752 funds tracked by Wall St. Rank hold CVS as of Q1 2025.
- Two Sigma Advisers reported no remaining CVS Health position as of Q1 2025 after selling out during the quarter.
- Two Sigma Advisers sold 836,100 CVS Health shares in Q1 2025, an estimated $37.5M.
- Two Sigma Advisers first reported a position in CVS Health in Q2 2013 and held it in 32 quarters.
- Two Sigma Advisers's CVS Health position peaked at $406M in Q1 2023.
- 1,752 funds tracked by Wall St. Rank held CVS Health as of Q1 2025.
Based on Two Sigma Advisers's 13F filing for Q1 2025, filed 15 May 2025.